{"entity":{"type":"insider","cik":"0001361712","url":"/insider/0001361712","json_url":"/insider/0001361712.json","name":"Stampacchia Otello","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":318,"n_filings":91,"first":"2007-06-26","last":"2025-07-30","span_basis":"filed_date"},"name_variants":[{"name":"Stampacchia Otello","source":"filing","n_filings":91,"first_seen":"2007-06-26","last_seen":"2025-07-30"}],"transactions":[{"id":4770882,"accession":"0001415889-25-020598","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-020598","line_url":"/filing/0001415889-25-020598#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"ImageneBio, Inc.","issuer_ticker":"IMA","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":"0001361712","owner_name":"Stampacchia Otello","owner_display_name":"Stampacchia Otello","owner_url":"/insider/0001361712","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":267556.0,"shares_display":"267,556","price_per_share":29.9,"price_display":"29.90","price_state":"stated","total_value":7999924.4,"total_display":"7,999,924.40","total_whole":"7,999,924","shares_owned_after":454982.0,"shares_owned_after_display":"454,982","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-25","filed_date":"2025-07-30","scope":"insider"},{"id":8630855,"accession":"0001209191-23-054913","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-054913","line_url":"/filing/0001209191-23-054913#line-3","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Paster Anne-Mari; Omega Fund VI GP Manager, Ltd.; Stampacchia Otello; Omega Fund VI, L.P.; Omega Fund VI GP, L.P.; Nessi Claudio","owner_display_name":"Paster Anne-Mari","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":454545.0,"shares_display":"454,545","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":2157623.0,"shares_owned_after_display":"2,157,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-07","filed_date":"2023-11-09","scope":"insider"},{"id":6767336,"accession":"0000899243-22-011332","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-011332","line_url":"/filing/0000899243-22-011332","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.; Omega Fund IV, L.P.","owner_display_name":"Omega Fund IV G.P. Manager, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":15.516730666666666,"price_display":"15.52","price_state":"stated","total_value":698252.88,"total_display":"698,252.88","total_whole":"698,253","shares_owned_after":4673380.0,"shares_owned_after_display":"4,673,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-16","scope":"insider","n_lines":2},{"id":6767332,"accession":"0000899243-22-011332","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-011332","line_url":"/filing/0000899243-22-011332#line-3","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.; Omega Fund IV, L.P.","owner_display_name":"Omega Fund IV G.P. Manager, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":15.64,"price_display":"15.64","price_state":"stated","total_value":703800.0,"total_display":"703,800.00","total_whole":"703,800","shares_owned_after":4718380.0,"shares_owned_after_display":"4,718,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-16","scope":"insider"},{"id":6767329,"accession":"0000899243-22-011332","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-011332","line_url":"/filing/0000899243-22-011332#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.; Omega Fund IV, L.P.","owner_display_name":"Omega Fund IV G.P. Manager, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16500.0,"shares_display":"16,500","price_per_share":15.42,"price_display":"15.42","price_state":"stated","total_value":254430.0,"total_display":"254,430.00","total_whole":"254,430","shares_owned_after":4763380.0,"shares_owned_after_display":"4,763,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-14","filed_date":"2022-03-16","scope":"insider"},{"id":4605363,"accession":"0000899243-21-045798","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-045798","line_url":"/filing/0000899243-21-045798#line-3","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV, L.P.; Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.","owner_display_name":"Omega Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10162.0,"shares_display":"10,162","price_per_share":34.7,"price_display":"34.70","price_state":"stated","total_value":352621.4,"total_display":"352,621.40","total_whole":"352,621","shares_owned_after":4763380.0,"shares_owned_after_display":"4,763,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-23","scope":"insider"},{"id":4605359,"accession":"0000899243-21-045798","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-045798","line_url":"/filing/0000899243-21-045798","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV, L.P.; Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.","owner_display_name":"Omega Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35262.0,"shares_display":"35,262","price_per_share":34.54307469797516,"price_display":"34.54","price_state":"stated","total_value":1218057.9,"total_display":"1,218,057.90","total_whole":"1,218,058","shares_owned_after":4773959.0,"shares_owned_after_display":"4,773,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-23","scope":"insider","n_lines":2},{"id":5526161,"accession":"0000899243-21-045302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-045302","line_url":"/filing/0000899243-21-045302#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.; Omega Fund IV, L.P.","owner_display_name":"Omega Fund IV G.P. Manager, Ltd.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2441.0,"shares_display":"2,441","price_per_share":33.5,"price_display":"33.50","price_state":"stated","total_value":81773.5,"total_display":"81,773.50","total_whole":"81,774","shares_owned_after":4808804.0,"shares_owned_after_display":"4,808,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-18","scope":"insider"},{"id":4088650,"accession":"0000899243-21-045301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-045301","line_url":"/filing/0000899243-21-045301#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Stampacchia Otello; Omega Fund IV, L.P.; Omega Fund IV GP, L.P.; Omega Fund IV G.P. Manager, Ltd.","owner_display_name":"Stampacchia Otello","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2441.0,"shares_display":"2,441","price_per_share":33.5,"price_display":"33.50","price_state":"stated","total_value":81773.5,"total_display":"81,773.50","total_whole":"81,774","shares_owned_after":4808804.0,"shares_owned_after_display":"4,808,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-18","scope":"insider"},{"id":5526157,"accession":"0000899243-21-045302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-045302","line_url":"/filing/0000899243-21-045302#line-1","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.; Omega Fund IV, L.P.","owner_display_name":"Omega Fund IV G.P. Manager, Ltd.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153.0,"shares_display":"153","price_per_share":33.5,"price_display":"33.50","price_state":"stated","total_value":5125.5,"total_display":"5,125.50","total_whole":"5,126","shares_owned_after":4811245.0,"shares_owned_after_display":"4,811,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"},{"id":4088645,"accession":"0000899243-21-045301","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-045301","line_url":"/filing/0000899243-21-045301#line-1","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Stampacchia Otello; Omega Fund IV, L.P.; Omega Fund IV GP, L.P.; Omega Fund IV G.P. Manager, Ltd.","owner_display_name":"Stampacchia Otello","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153.0,"shares_display":"153","price_per_share":33.5,"price_display":"33.50","price_state":"stated","total_value":5125.5,"total_display":"5,125.50","total_whole":"5,126","shares_owned_after":4811245.0,"shares_owned_after_display":"4,811,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"},{"id":4564253,"accession":"0000899243-21-044774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-044774","line_url":"/filing/0000899243-21-044774#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV GP, L.P.; Stampacchia Otello; Omega Fund IV G.P. Manager, Ltd.; Omega Fund IV, L.P.","owner_display_name":"Omega Fund IV GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":782.0,"shares_display":"782","price_per_share":33.66,"price_display":"33.66","price_state":"stated","total_value":26322.12,"total_display":"26,322.12","total_whole":"26,322","shares_owned_after":4811398.0,"shares_owned_after_display":"4,811,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-16","scope":"insider"},{"id":4564248,"accession":"0000899243-21-044774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-044774","line_url":"/filing/0000899243-21-044774#line-1","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV GP, L.P.; Stampacchia Otello; Omega Fund IV G.P. Manager, Ltd.; Omega Fund IV, L.P.","owner_display_name":"Omega Fund IV GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23235.0,"shares_display":"23,235","price_per_share":33.66,"price_display":"33.66","price_state":"stated","total_value":782090.1,"total_display":"782,090.10","total_whole":"782,090","shares_owned_after":4812180.0,"shares_owned_after_display":"4,812,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-16","scope":"insider"},{"id":5277088,"accession":"0000899243-21-044322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-044322","line_url":"/filing/0000899243-21-044322#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV, L.P.; Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.","owner_display_name":"Omega Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18279.0,"shares_display":"18,279","price_per_share":33.61,"price_display":"33.61","price_state":"stated","total_value":614357.19,"total_display":"614,357.19","total_whole":"614,357","shares_owned_after":4835415.0,"shares_owned_after_display":"4,835,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-12","scope":"insider"},{"id":5277086,"accession":"0000899243-21-044322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-044322","line_url":"/filing/0000899243-21-044322#line-1","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV, L.P.; Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.","owner_display_name":"Omega Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11.0,"shares_display":"11","price_per_share":33.5,"price_display":"33.50","price_state":"stated","total_value":368.5,"total_display":"368.50","total_whole":"369","shares_owned_after":4853694.0,"shares_owned_after_display":"4,853,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-12","scope":"insider"},{"id":5088014,"accession":"0000899243-21-043855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-043855","line_url":"/filing/0000899243-21-043855#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Stampacchia Otello; Omega Fund IV GP, L.P.; Omega Fund IV G.P. Manager, Ltd.; Omega Fund IV, L.P.","owner_display_name":"Stampacchia Otello","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7537.0,"shares_display":"7,537","price_per_share":33.73,"price_display":"33.73","price_state":"stated","total_value":254223.01,"total_display":"254,223.01","total_whole":"254,223","shares_owned_after":4853705.0,"shares_owned_after_display":"4,853,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-09","filed_date":"2021-11-10","scope":"insider"},{"id":5088013,"accession":"0000899243-21-043855","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-043855","line_url":"/filing/0000899243-21-043855#line-1","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Stampacchia Otello; Omega Fund IV GP, L.P.; Omega Fund IV G.P. Manager, Ltd.; Omega Fund IV, L.P.","owner_display_name":"Stampacchia Otello","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3817.0,"shares_display":"3,817","price_per_share":33.53,"price_display":"33.53","price_state":"stated","total_value":127984.01,"total_display":"127,984.01","total_whole":"127,984","shares_owned_after":4861242.0,"shares_owned_after_display":"4,861,242","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-08","filed_date":"2021-11-10","scope":"insider"},{"id":5133475,"accession":"0000899243-21-043456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-043456","line_url":"/filing/0000899243-21-043456#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV, L.P.; Omega Fund IV G.P. Manager, Ltd.; Omega Fund IV GP, L.P.; Stampacchia Otello","owner_display_name":"Omega Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5790.0,"shares_display":"5,790","price_per_share":33.5,"price_display":"33.50","price_state":"stated","total_value":193965.0,"total_display":"193,965.00","total_whole":"193,965","shares_owned_after":4865059.0,"shares_owned_after_display":"4,865,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-08","scope":"insider"},{"id":5133470,"accession":"0000899243-21-043456","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-043456","line_url":"/filing/0000899243-21-043456#line-1","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV, L.P.; Omega Fund IV G.P. Manager, Ltd.; Omega Fund IV GP, L.P.; Stampacchia Otello","owner_display_name":"Omega Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25225.0,"shares_display":"25,225","price_per_share":33.58,"price_display":"33.58","price_state":"stated","total_value":847055.5,"total_display":"847,055.50","total_whole":"847,056","shares_owned_after":4870849.0,"shares_owned_after_display":"4,870,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-08","scope":"insider"},{"id":5431928,"accession":"0000899243-21-040245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-040245","line_url":"/filing/0000899243-21-040245#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Theseus Pharmaceuticals, Inc.","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Paster Anne-Mari; Omega Fund VI GP Manager, Ltd.; Nessi Claudio; Omega Fund VI, L.P.; Stampacchia Otello","owner_display_name":"Paster Anne-Mari","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":711479.0,"shares_owned_after_display":"711,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-12","filed_date":"2021-10-14","scope":"insider"},{"id":4451596,"accession":"0000899243-21-037893","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-037893","line_url":"/filing/0000899243-21-037893#line-1","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV GP, L.P.; Omega Fund IV, L.P.","owner_display_name":"Omega Fund IV G.P. Manager, Ltd.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12171.0,"shares_display":"12,171","price_per_share":33.58,"price_display":"33.58","price_state":"stated","total_value":408702.18,"total_display":"408,702.18","total_whole":"408,702","shares_owned_after":4896074.0,"shares_owned_after_display":"4,896,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-23","filed_date":"2021-09-27","scope":"insider"},{"id":4826215,"accession":"0000899243-21-036546","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-036546","line_url":"/filing/0000899243-21-036546","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV, L.P.; Omega Fund IV GP, L.P.","owner_display_name":"Omega Fund IV G.P. Manager, Ltd.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94463.0,"shares_display":"94,463","price_per_share":33.01588336173952,"price_display":"33.02","price_state":"stated","total_value":3118779.39,"total_display":"3,118,779.39","total_whole":"3,118,779","shares_owned_after":4923710.0,"shares_owned_after_display":"4,923,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-20","scope":"insider","n_lines":2},{"id":4826205,"accession":"0000899243-21-036546","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-036546","line_url":"/filing/0000899243-21-036546#line-1","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund IV G.P. Manager, Ltd.; Stampacchia Otello; Omega Fund IV, L.P.; Omega Fund IV GP, L.P.","owner_display_name":"Omega Fund IV G.P. Manager, Ltd.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5537.0,"shares_display":"5,537","price_per_share":32.55,"price_display":"32.55","price_state":"stated","total_value":180229.35,"total_display":"180,229.35","total_whole":"180,229","shares_owned_after":5002708.0,"shares_owned_after_display":"5,002,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-16","filed_date":"2021-09-20","scope":"insider"},{"id":5427842,"accession":"0000899243-21-017711","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-017711","line_url":"/filing/0000899243-21-017711","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund V, L.P.; Omega Fund V GP, L.P.; Omega Fund V GP Manager, Ltd.; Stampacchia Otello","owner_display_name":"Omega Fund V, L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9487.0,"shares_display":"9,487","price_per_share":55.135995572889215,"price_display":"55.14","price_state":"stated","total_value":523075.19,"total_display":"523,075.19","total_whole":"523,075","shares_owned_after":2071768.0,"shares_owned_after_display":"2,071,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-30","filed_date":"2021-05-03","scope":"insider","n_lines":3},{"id":5427836,"accession":"0000899243-21-017711","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-017711","line_url":"/filing/0000899243-21-017711","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund V, L.P.; Omega Fund V GP, L.P.; Omega Fund V GP Manager, Ltd.; Stampacchia Otello","owner_display_name":"Omega Fund V, L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7671.0,"shares_display":"7,671","price_per_share":54.045971842002345,"price_display":"54.05","price_state":"stated","total_value":414586.65,"total_display":"414,586.65","total_whole":"414,587","shares_owned_after":2082245.0,"shares_owned_after_display":"2,082,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-29","filed_date":"2021-05-03","scope":"insider","n_lines":3},{"id":4921222,"accession":"0000899243-21-017342","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-017342","line_url":"/filing/0000899243-21-017342","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund V GP, L.P.; Omega Fund V GP Manager, Ltd.; Omega Fund V, L.P.; Stampacchia Otello","owner_display_name":"Omega Fund V GP, L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3366.0,"shares_display":"3,366","price_per_share":55.71472370766488,"price_display":"55.71","price_state":"stated","total_value":187535.76,"total_display":"187,535.76","total_whole":"187,536","shares_owned_after":2086071.0,"shares_owned_after_display":"2,086,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-28","filed_date":"2021-04-29","scope":"insider","n_lines":2},{"id":4921209,"accession":"0000899243-21-017342","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-017342","line_url":"/filing/0000899243-21-017342","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund V GP, L.P.; Omega Fund V GP Manager, Ltd.; Omega Fund V, L.P.; Stampacchia Otello","owner_display_name":"Omega Fund V GP, L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7338.0,"shares_display":"7,338","price_per_share":55.28998364677024,"price_display":"55.29","price_state":"stated","total_value":405717.9,"total_display":"405,717.90","total_whole":"405,718","shares_owned_after":2089769.0,"shares_owned_after_display":"2,089,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-27","filed_date":"2021-04-29","scope":"insider","n_lines":3},{"id":5131691,"accession":"0000899243-21-017064","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-21-017064","line_url":"/filing/0000899243-21-017064","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Stampacchia Otello; Omega Fund V GP, L.P.; Omega Fund V, L.P.; Omega Fund V GP Manager, Ltd.","owner_display_name":"Stampacchia Otello","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5146.0,"shares_display":"5,146","price_per_share":56.547477652545666,"price_display":"56.55","price_state":"stated","total_value":290993.32,"total_display":"290,993.32","total_whole":"290,993","shares_owned_after":2098048.0,"shares_owned_after_display":"2,098,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-26","filed_date":"2021-04-27","scope":"insider","n_lines":3},{"id":5131676,"accession":"0000899243-21-017064","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-017064","line_url":"/filing/0000899243-21-017064","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Stampacchia Otello; Omega Fund V GP, L.P.; Omega Fund V, L.P.; Omega Fund V GP Manager, Ltd.","owner_display_name":"Stampacchia Otello","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8672.0,"shares_display":"8,672","price_per_share":55.67058694649447,"price_display":"55.67","price_state":"stated","total_value":482775.33,"total_display":"482,775.33","total_whole":"482,775","shares_owned_after":2103623.0,"shares_owned_after_display":"2,103,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-23","filed_date":"2021-04-27","scope":"insider","n_lines":4},{"id":4508660,"accession":"0000899243-21-016863","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-21-016863","line_url":"/filing/0000899243-21-016863","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund V GP Manager, Ltd.; Omega Fund V GP, L.P.; Omega Fund V, L.P.; Stampacchia Otello","owner_display_name":"Omega Fund V GP Manager, Ltd.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12235.0,"shares_display":"12,235","price_per_share":57.54593951777687,"price_display":"57.55","price_state":"stated","total_value":704074.57,"total_display":"704,074.57","total_whole":"704,075","shares_owned_after":2114922.0,"shares_owned_after_display":"2,114,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-22","filed_date":"2021-04-23","scope":"insider","n_lines":5},{"id":4508646,"accession":"0000899243-21-016863","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-016863","line_url":"/filing/0000899243-21-016863#line-4","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Omega Fund V GP Manager, Ltd.; Omega Fund V GP, L.P.; Omega Fund V, L.P.; Stampacchia Otello","owner_display_name":"Omega Fund V GP Manager, Ltd.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3523.0,"shares_display":"3,523","price_per_share":57.48,"price_display":"57.48","price_state":"stated","total_value":202502.04,"total_display":"202,502.04","total_whole":"202,502","shares_owned_after":2122828.0,"shares_owned_after_display":"2,122,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-23","scope":"insider"}],"collapsed":true,"next_cursor":"2021-04-21|4508646","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":49,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001835579","name":"ImageneBio, Inc.","url":"/issuer/0001835579","role":"Director","n_filings":1,"first_seen":"2025-07-30","last_seen":"2025-07-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001907108","name":"Lexeo Therapeutics, Inc.","url":"/issuer/0001907108","role":"Ten percent owner","n_filings":1,"first_seen":"2023-11-09","last_seen":"2023-11-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001737953","name":"Replimune Group, Inc.","url":"/issuer/0001737953","role":"Director, Ten percent owner","n_filings":16,"first_seen":"2018-07-25","last_seen":"2022-03-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001745020","name":"Theseus Pharmaceuticals, Inc.","url":"/issuer/0001745020","role":"Other","n_filings":1,"first_seen":"2021-10-14","last_seen":"2021-10-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001679363","name":"Morphic Holding, Inc.","url":"/issuer/0001679363","role":"Director, Ten percent owner","n_filings":41,"first_seen":"2019-07-01","last_seen":"2021-05-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001832010","name":"Omega Alpha SPAC","url":"/issuer/0001832010","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":1,"first_seen":"2021-01-13","last_seen":"2021-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001741830","name":"Kronos Bio, Inc.","url":"/issuer/0001741830","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2020-10-16","last_seen":"2020-10-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001728117","name":"Gossamer Bio, Inc.","url":"/issuer/0001728117","role":"Director, Ten percent owner, Other","n_filings":3,"first_seen":"2019-09-09","last_seen":"2019-09-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001131907","name":"MICROMET, INC.","url":"/issuer/0001131907","role":"Director, Ten percent owner","n_filings":25,"first_seen":"2007-06-26","last_seen":"2010-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001361712","retrieved_at":"2026-08-25T20:22:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}